Haag-Molkenteller Cornelia 4
4 · Urovant Sciences Ltd. · Filed Jan 8, 2019
Insider Transaction Report
Form 4
Haag-Molkenteller Cornelia
CMO of Urovant Sciences, Inc.
Transactions
- Award
Stock Option (Right to Buy)
2019-01-06+100,000→ 100,000 totalExercise: $6.88Exp: 2029-01-06→ Common Shares (100,000 underlying)
Footnotes (1)
- [F1]25% of the total shares underlying the option shall vest and become exercisable on January 2, 2020; the remaining shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.